FDA Recalls Potassium Chloride Capsules Over Heart Attack Risk

Glenmark Pharmaceuticals and American Health Packaging pull 135 batches due to faulty dissolution mechanism leading to hyperkalemia concerns.

The recall involves 114 batches from Glenmark Pharmaceuticals and 21 batches from American Health Packaging.
Faulty dissolution of the capsules could cause high potassium levels, potentially leading to cardiac arrest.
No reports of adverse events or hyperkalemia have been recorded so far.
Consumers are advised to consult healthcare providers before discontinuing use of the recalled product.
Affected distributors are instructed to arrange returns through written notifications.